Advances in Diabetes and Endocrinology

The Centers for Diabetes Care at NewYork-Presbyterian take an active role in using innovative treatments and educating the public on how to prevent this chronic disease. They also address a wide range of metabolic and endocrine disorders, including primary hyperparathyroidism, osteoporosis, transplantation-related bone disease, and Paget's Disease. The Naomi Berrie Diabetes Center at NewYork-Presbyterian/Columbia University Irving Medical Center is one of three Diabetes Centers of Excellence in New York State and has been cited by the American Diabetes Association for its quality care.

Imaging of beta cells

Enhancing the Functionality of Pancreatic Beta Cells in Type 2 Diabetes

Weill Cornell Medicine endocrinologists discover a novel mechanism to stimulate growth of pancreatic beta cells in a preclinical model of type 2 diabetes.

A measuring tape and pills

Assessing Long-Term Outcomes of Anti-Obesity Medications

Weill Cornell Medicine’s Comprehensive Weight Control Center is at the forefront of research for anti-obesity medications that potentially help individuals lose between 5% to 10% of their body weight.

image of metabolic bone disease schematic

The Complex Relationship Between Celiac Disease and Metabolic Bone Disease

NewYork-Presbyterian/Columbia physicians identify multiple areas of investigation to develop standardized guidelines for the screening and treatment of bone disease in patients with celiac disease.

A Weill Cornell Medicine transplant surgeon and obesity specialist evaluates the potential impact of the recent changes to the eGFR on obesity medications for Black patients with chronic kidney disease.

The Double Bind of Obesity and Chronic Kidney Disease: Evaluating the Impact of the Revised eGFR Formula

A Weill Cornell Medicine transplant surgeon and obesity specialist evaluates the potential impact of the recent changes to the eGFR on obesity medications for Black patients with chronic kidney disease.

microscopic image of fatty liver disease showing triglyceride fat cells

Insulin Resistance: A Pathway to Research in Fatty Liver Disease?

A Columbia endocrinologist merges his clinical practice and research pursuits to understand the role of insulin resistance in the development of fatty liver disease.

image of Insulin, pump, and infusion set

Insulin Pumps and Continuous Glucose Monitors: Understanding Their Use in the Hospital Setting

Weill Cornell Medicine endocrinologists present current guidelines and available evidence on the continuation of insulin pumps and CGMs by patients when admitted to the hospital.

image of demonstration of radiofrequency ablation for thyroid nodules

Thyroid Nodules: Series of Clinical Trials Show the Promise of Radiofrequency Ablation

Columbia endocrine surgeon-scientist evaluates minimally invasive treatment for benign thyroid nodules.

image of weight scale and tape measure

New Medication Surmounts the Challenges of Weight Control

Weill Cornell Medicine obesity medicine specialist served as co-investigator in the SURMOUNT-1 phase 3 trial of tirzepatide, which achieved unprecedented levels of weight loss in adults with obesity.

3D Illustration of bone structure affected by osteoporosis

Confronting the Challenges of Osteoporosis Management in Younger Adults

Columbia endocrinologist defines dilemmas in diagnosis and management of early-onset osteoporosis, exposing the barriers to care and proposing a framework for effective treatment.

image of telemedicine physician consultation

A Role for Telemedicine in Weight Loss Management

Weill Cornell Medicine endocrinologists and weight control specialists compare effectiveness of the telemedicine model versus in-person care.

image of Vitamin D capsules

The Multiple Implications of Vitamin D Deficiency

Columbia endocrinologists investigate its role in disease and health and explore its significance for COVID-19.

image of Dr. Jennifer Kuo

Interventional Endocrinology: An Emerging Specialty

Doctors at NewYork-Presbyterian/Columbia are looking to interventional endocrinology, an emerging specialty that uses percutaneous, image-guided, less-invasive procedures to address endocrine disorders that offers an alternative to surgery.

image of Dr. Thomas J. Fahey, III

Exploring Novel Treatments for Thyroid Cancer

Under the direction of Dr. Thomas J. Fahey, III, researchers at Weill Cornell Medicine have identified the use of gene expression analysis to discriminate benign and malignant thyroid nodules.

image of Dr. Judith Korner

Meeting the Pressing Need for Evidence-Based Obesity Care

Research is a key component of the Weight Control Center. Dr. Korner is the principal investigator of an NIH-funded study to understand the hormonal regulation of appetite and energy balance.

image of Dr. Felicia A. Mendelsohn Curanaj

Managing the Challenges of Pregnancy and Diabetes

Physicians at Weill Cornell Medicine reviewed the diagnostic criteria for diabetes in pregnancy; types of therapies available to prevent hyperglycemia; and strategies for reaching inpatient glycemic targets during the peripartum period.

image of Dr. Marcus D. Goncalves

Regulating Metabolism in the Setting of Cancer

Dr. Goncalves has developed a mouse model that recapitulates the cachexia syndrome as they seek interventions – either dietary or metabolic – to help prevent muscle wasting and fat loss.

image of Dr. Magdalena M. Bogun

Pathways to Diabetes Prevention: It’s All Relative

We found that insulin production decreases long before a patient is actually diagnosed with type 1 diabetes. Now that we know that a reduction in insulin production begins earlier on, we can diagnose T1D earlier in patients with antibody screening. So the question became how do we reach these individuals.

Newsletters for Medical Professionals

2022 Issue 1

2021 Issue 2

2021 Issue 1

2019 Issue 2

2019 Issue 1

2018 Issue 2

2018 Issue 1

2017 Issue 1

Spring/Summer 2016